Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 10Triptorelin literaturebiorxiv-preprint · Observational2025

Reproductive Axis Recovery Post Ovarian Stimulation and Gonadotropin Releasing Hormone Agonist (GnRH-a) Trigger, Observational Case Series

Triptorelin may delay ovulation by about one week in the natural cycle following ovarian stimulation, which could affect the timing of frozen embryo transfers.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the triptorelin corpus
0
Preclinical
8
Observational · this one
0
Open-label
1
Randomised
1
Reviews

Summary and findings

This observational case series examined the impact of Triptorelin (0.2 mg) on the reproductive axis following ovarian stimulation in 100 IVF patients. The study found that ovulation occurred later than expected in the subsequent natural cycle. Specifically, ovulation was delayed to cycle day 21, compared to the predicted cycle day 14.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Ovulation was delayed to cycle day 21, compared to the predicted cycle day 14.2025

Abstract

The authors’ words, as biorxiv-preprint supplied them

Background: Following GnRH agonist trigger and "freeze all" in order to prevent ovarian hyperstimulation syndrome (OHSS), patients are usually anxious to continue immediately with a frozen embryo transfer (FET). Currently, the preferred FET protocol in based on natural or induced ovulation. Objectives: Do ovarian stimulation and GnRH-a, used to trigger final oocyte maturation, affect the reproductive axis in the next natural cycle? Design: An observational case series of 100 subsequent IVF patients to whom GnRH-a (Triptorelin 0.2 mg) was given for final oocyte maturation in the context of ovarian hyper-stimulation syndrome prevention, followed by embryos "freeze all". Methods: In the next natural cycle, patients were followed to detect a dominant follicle (≥17 mm), at which time ovulation was triggered with hCG (250 µg), and FET was scheduled according to embryo's age on freezing day. Results: Whereas natural ovulation according to pre-IVF treatment was predicted to be on cycle day 14, the actual ovulation in our patients was on day 21. In eight patients follicular activity was not detected after 15-28 days, therefore the natural cycle frozen embryo transfer approach was abandoned. Conclusions: Ovarian stimulation and GnRH-a used to trigger final oocyte maturation in IVF patients inhibits the reproductive axis for days. Therefore, natural ovulation in the subsequent cycle may be deferred for about one week relative to the patient's pre-IVF menstrual cycle pattern.

Elsewhere in the Triptorelin corpus

AComparative effectiveness of luteal phase support strategies in natural cycle frozen-thawed embryo transfer: a systematic review and network meta-analysis.European journal of obstetrics, gynecology, and reproductive biology · 2026 · Not reported in abstract.reviewCProposed Method for Mass Spectrometric Measurement of the Gonadotropin-Releasing Hormone Agonist Deslorelin.Toxics · 2026 · Detectability optimized to <1 ppb.AnimalBComparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study.Urologic oncology · 2026 · n=6666 · HR for MACE with LHRH-AG vs LHRH-AN was 0.86, 95% CI: 0.79-0.93.HumanAEvaluation of triplet therapy combined with robot-assisted cytoreductive prostatectomy for high-volume metastatic prostate cancer: a multicentre randomised controlled trial protocol.BJU international · 2026 · n=88 · Not reported in abstract.HumanBOptimizing ovarian stimulation in oocyte donation: exploratory comparison of rhFSH (2:1) versus hp-hMG under PPOS protocols.JBRA assisted reproduction · 2023 · n=36 · Mean number of good-morphology blastocysts per cycle was 4.5 with rhFSH:rhLH vs 2.0 with hp-hMG.HumanBTreatment Outcomes in 84 Male Children with Accelerated Pubertal Progression: A Comparative Analysis ofGnRHa, Combined GH Therapy and Aromatase Inhibitorbiorxiv-preprint · 2026 · ΔH/y of combination therapy was 8.49 ± 3.22 cm/y, GnRHa was 6.73 ± 1.95 cm/y, and AI was 7.75 ± 1.92 cm/y, P < 0.01.Human